| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
|
Obamiro, Kehinde O.
|
|
2018
|
23 |
4 |
p. 337-343
|
artikel
|
| 2 |
Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) Rat
|
Younis, Firas
|
|
2018
|
23 |
4 |
p. 358-371
|
artikel
|
| 3 |
Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation
|
White, William B.
|
|
2018
|
23 |
4 |
p. 309-317
|
artikel
|
| 4 |
Coronary Artery Development: Origin, Malformations, and Translational Vascular Reparative Therapy
|
Ramai, Daryl
|
|
2018
|
23 |
4 |
p. 292-300
|
artikel
|
| 5 |
Corrigendum
|
|
|
2018
|
23 |
4 |
p. 372
|
artikel
|
| 6 |
Does p53 Inhibition Suppress Myocardial Ischemia–Reperfusion Injury?
|
Yano, Toshiyuki
|
|
2018
|
23 |
4 |
p. 350-357
|
artikel
|
| 7 |
Effects of Enoxaparin on Intravascular Sclerostin Release in Healthy Men
|
Borawski, Jacek
|
|
2018
|
23 |
4 |
p. 344-349
|
artikel
|
| 8 |
Efficacy and Safety of S-Amlodipine 2.5 and 5 mg/d in Hypertensive Patients Who Were Treatment-Naive or Previously Received Antihypertensive Monotherapy
|
Şen, Selçuk
|
|
2018
|
23 |
4 |
p. 318-328
|
artikel
|
| 9 |
Opioids in Cardiovascular Disease: Therapeutic Options
|
Rawal, Hemangi
|
|
2018
|
23 |
4 |
p. 279-291
|
artikel
|
| 10 |
The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of Hypercholesterolemia
|
White, C. Michael
|
|
2018
|
23 |
4 |
p. 301-308
|
artikel
|
| 11 |
Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
|
Admassie, Endalkachew
|
|
2018
|
23 |
4 |
p. 329-336
|
artikel
|
Tijdschrift beschrijving